| Bioactivity | TBC-1 is a chlorophyll-a derivative, is a photosensitizer that can be used in photodynamic therapy (PDT). TBC-1 efficiently generats Type-I ROS and endoplasmic reticulum targeting ability. TBC-1 shows biocompatibility and PDT efficiency in vitro under both normoxia and hypoxia[1]. |
| CAS | 2522115-48-4 |
| Formula | C31H28BrN3O3 |
| Molar Mass | 570.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rui Yuan, et al. Tröger’s Base as a Potential Bridge to Type-I Photosensitizers: Mechanism and Antitumor Applications. J Med Chem. 2025 Jan 7. |